NLR与肿瘤同步放化疗预后的相关性研究

doi:10.11904/j.issn.1002-3070.2019.03.018

Abstract

Abstract: By now,the clinical methods of cancer treatment are mainly surgery,radiotherapy,chemotherapy,and traditional Chinese medicine methods.However,some tumors are concealed due to onset,initial diagnosis and treatment,which have entered the middle and late stage,lost the operation opportunity and impossible to pass accurate surgical staging by assessment of prognosis.Radical concurrent chemoradiotherapy can be used for tumors that are inoperable and sensitive to radiation therapy.Therefore,it has become a hot spot to explore accurate and economic indicators to evaluate the prognosis of radiotherapy and chemotherapy.Neutrophil to lymphocyte ratio(NLR)refers to the ratio of neutrophils to lymphocytes in peripheral blood before treatment.As a general indicator of systemic inflammatory response,many studies have confirmed that the relationship between the efficacy of radiotherapy and chemotherapy for tumors provides a new way to evaluate the prognosis of tumors.This article briefly reviews the relationship between NLR and the prognosis of tumor-controlled radiotherapy and chemotherapy.

Key words: NLR, Concurrent chemoradiotherapy, Prognosis

CLC Number:

FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy[J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.

References

1 Kuang DM,Zhao Q,Wu Y,et al.Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma[J].J Hepatol,2011,54(5):948-955.
2 Mehrazin R,Uzzo RG,Kutikov A,et al.Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma[J].Urol Oncol,2015,191(4):321-322.
3 Mantovani A,Allavena P,Sica A,et al.Cancer-related inflammation[J].Nature,2008,454(7203):436-444.
4 Mizunuma M,Yokoyama Y,Futagami M,et al.The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer[J].J Clin Oncol,2015,20(5):989-996.
5 Ding PR,An X,Zhang RX,et al.Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer[J].Int J Colorectal Dis,2010,25(12):1427-1433.
6 Zhang J,Huang SH,Li H,et al.Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer[J].Med Oncol,2013,30(1):1-7.
7 Ardi VC,Kupriyanova TA,Deryugina EI,et al.Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis[J].Proc Natl Acad Sci U S A,2007,104(51):20262-20267.
8 Msph LAT,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
9 Mizunuma M,Yokoyama Y,Futagami M,et al.The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer[J].J Clin Oncol,2015,20(5):989-996.
10 Lee Y,Choi CH,Kim H,et al.Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma[J].Anticancer Res,2012,32(4):1555.
11 Onal C,Guler OC,Yildirim BA.Prognostic use of pretreatment hematologic parameters in patients receiving definitive chemoradiotherapy for cervical cancer[J].Int J Gynecol Cancer,2016,26(6):1.
12 Wang YY,Bai ZL,He JL,et al.Prognostic value of neutrophil-related factors in locally advanced cervical squamous cell carcinoma patients treated with cisplatin-based concurrent chemoradiotherapy[J].Dis Markers,2016,40(12):1-9.
13 Najjar YG,Finke JH.Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer[J].Front Oncol,2013,3:49.
14 Lee N,Harris J,Garden AS,et al.Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma:radiation therapy oncology group phase II trial 0225[J].J Clin Oncol,2009,27(22):3684.
15 Sun W,Zhang L,Luo M,et al.Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma:neutrophil-lymphocyte ratio and platelet-lymphocyte ratio[J].Head Neck,2016,38(S1):1332-1340.
16 He JR,Shen G,Ren ZF,et al.Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma[J].Head Neck,2012,34(12):1769-1776.
17 Guo SP,Liu ZG,Tu ZW,et al.Haemoglobin,neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma:development and validation in 3237 patients from a single institution[J].J Clin Oncol,2013,25(11):639-646.
18 Li AC,Xiao WW,Wang L,et al.Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy[J].Tumour Biol,2015,36(11):8349-8357.
19 An X,Ding PR,Wang FH,et al.Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma[J].Tumor Biol,2011,32(2):317-324.
20 李晓惠,徐冰清,高劲,等.中性粒细胞与淋巴细胞比值对鼻咽癌放射敏感性及预后影响的研究[J].中华放射肿瘤学杂志,2016,25(5):432-436.
21 Siegel RL,Miller KD,Fedewa SA,et al.Colorectal cancer statistics,2017[J].CA Cancer J Clin,2017,67(3):104-17.
22 Howington JA,Blum MG,Chang AC,et al.Treatment of stage I and II non-small cell lung cancer:Diagnosis and management of lung cancer,3rd ed:American college of chest physicians evidence-based clinical practice guidelines[J].Chest,2013,143(5):278-313.
23 Cannon NA,Meyer J,Iyengar P,et al.Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors following stereotactic radiation therapy for early-stage non-small cell lung cancer[J].J Thorac Oncol,2015,10(2):280-285.
24 Shaverdian N,Veruttipong D,Wang J,et al.Pretreatment immune parameters predict for overall survival and toxicity in early-stage non-dmall-cell lung cancer patients treated with stereotactic body radiation therap[J].Clin Lung Cancer,2016,17(1):39-46.
25 Luo H,Ge H,Cui Y,et al.Systemic inflammation biomarkers predict survival in patients of early stage non-small cell lung cancer treated with stereotactic ablative radiotherapy-a single center experience[J].J Cancer,2018,9(1):182-188.
26 Unal D,Eroglu C,Kurtul N,et al.Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis?[J].Asian Pac J Cancer Prev,2013,14(9):5237-5242.
27 Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136:359-386.
28 Chandrasekara S,Davis S,Thomson P,et al.High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy[J].Asia Pac J Clin Oncol,2018,14(5):442-447.
29 Moon H,Roh JL,Lee SW,et al.Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy[J].Radiother Oncol,2016,118(2):330-334.
30 Tempero MA,Malafa MP,Al-Hawary M,et al.Pancreatic adenocarcinoma,version 2.2017,NCCN clinical practice guidelines in oncology[J].Natl Compr Canc Netw,2017,15:1028-1061.
31 Konstantinidis IT,Warshaw AL,Allen JN,et al.Pancreatic ductal adenocarcinoma:is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?[J].Ann Surg,2013,257(4):731-736.
32 Lee BM,Chung SY,Chang JS,et al.The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are prognostic factors in patients with locally advanced pancreatic cancer treated with chemoradiotherapy[J].Gut Liver,2018,12(3):342-352.
33 Alagappan M,Pollom EL,Von ER,et al.Albumin and neutrophil-lymphocyte ratio(NLR)predict survival in patients with pancreatic adenocarcinoma treated with SBRT[J].Am J Clin Oncol,2018,41(3):242-247.
34 Romano F,Uggeri F,Crippa S,et al.Immunodeficiency in different histotypes of radically operable gastrointestinal cancers[J],J Exp Clin Cancer Res,2004,23(2):195-200.
35 Jang R,Darling G,Wong RK.Multimodality approaches for the curative treatment of esophageal cancer[J].J Natl Compr Canc Netw,2015,13(2):229-238.
36 Chen MF,Chen PT,Lu MS,et al.Survival benefit of surgery to patients with esophageal squamous cell carcinoma[J].Sci Rep,2017,7:46139.
37 Chen MF,Chen PT,Kuan FC,et al.The predictive value of pretreatment neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma[J].Ann Surg Oncol,2018,25(10):1-10.
38 Cox S,Hurt C,Grenader T,et al.The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy[J].Radiother Oncol,2017,125(1):154-159.
39 Yoo EJ,Park JC,Kim EH,et al.Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer[J].Dig Liver Dis,2014,46(9):846-853.

[1]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[2]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[3]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[4]	LU Jiaoyun, ZHANG Qingyuan. Advances in laboratory markers in the prognosis of diffuse large B-cell lymphoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 183-187.
[5]	ZHAO Fengjuan, WANG Qi, REN Yunhong, WEI Jueling, LI Lequn, ZHAO Xinhua, TANG Juan, YOU Xuemei. Changes of serum CRP and hs-CRP levels in patients with liver cancer and depression and their influence on prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 27-33.
[6]	ZHANG Fengchun, JIANG Ying, LIU Zhaonan, YAN Ningning, CUI Hongquan, XU Yingchun. Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indicators in gastric cancer patients after radical resection [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 34-39.
[7]	MA Jianli, ZHANG Minghui, JI Hongfei, XU Xiangying. Clinical significance of combined detection of PD-L1 protein and CD8⁺TILs in resected lung adenocarcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 40-46.
[8]	YANG Hongbo, SHI Jie, YE Yong, LI Wencheng, DENG Zhaoping. Expression of COL5A2 in bladder cancer tissues and its correlation with clinicopathological features and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 52-56.
[9]	WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei. Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 520-526.
[10]	TANG Shuli, HE Kuangbang, ZHANG Chunhui, CHENG Jianan, ZHANG Yanqiao. Expression of miR-320a and CYLD in gastric cancer and its relationship with clinicopathological characteristics and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 538-544.
[11]	XIAO Hongwei, CHEN Sheng, WANG Yanliang, SU Xueliang. The prognostic and influence factors analysis of transanal local resection for stage T₁ rectal cancer with the distance from anal margin ≤8 cm [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 545-549.
[12]	WANG Yiran, HUANG Wei, YIN Lei, LIU Lin, ZHOU Xiaoping, NIU Xingjian, YANG Yue, AN Weiwei, JI Hongfei. The ratio of neutrophil to lymphocyte in the efficacy and prognosis of concurrent chemoradiotherapy in patients with cervical cancer and its clinical significance [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 404-409.
[13]	LI Meiyan, CHEN Yongxue, HOU Junde. Effects of Leptin,VEGF and different anesthesia methods on prognosis of endometrial cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 426-431.
[14]	HAN Teng, TANG Liping. Advances in the relationship between the PD-L1 expression and the prognosis of gynecologic malignancies [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 468-470.
[15]	DU Lingbin,WEI Wenqiang. Progress research in survival analysis of esophageal squamous cell carcinoma(ESCC)in Chinese population [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 344-348.

Correlation between NLR and prognosis of concurrent chemoradiotherapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments